EPS growth is an important number as it indicates the future prospects of Cutera. The EPS growth rate, as it is usually called, is typically displayed as a percentage, which at this time is hard to estimate, but EPS was -114.29% over the last twelve months. The higher the EPS growth rate, the higher the value that is added to shareholders and a good reflection on the performance of the management at Cutera.
Cutera trades as part of the healthcare sector and is part of the medical devices industry. The company CEO is Robert Jason Richey. Cutera Inc is a medical device company. The company is engaged in designing, development, manufacturing, marketing and servicing of laser and other energy based aesthetics systems for practitioners.
Previous Intraday Performance:
The CUTR shares had a previous change of 1.36% which opened at 14.04 and closed at 14.14. It moved to an intraday high of 14.28 and a low of 13.76.
SeekingAlpha: Healthcare dominate midday movers
Over the last five trading days, CUTR shares returned -0.63% and in the past 30 trading days it returned -15.23%. Over three months, it changed -29.65%. In one year it has changed -69.33% and within that year its 52-week high was 56.05 and its 52-week low was 12.32. CUTR stock is 14.77% above its 52 Week Low.
Our calculations result in a 200 day moving average of 30.36 and a 50 day moving average of 15.69. Right now, CUTR stock is trading -53.43% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $196.6m with 13.9m shares outstanding and a float of 11.9m shares. Trading volume was 216,479 shares and has experienced an average volume of 264,510 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Cutera was 2.04 which ended on 31st of December 2017, which according to the previous close, that is a PE of 6.93. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.03.Historically, the PE high was 6.93 and the PE low was -353.50. If the stock reached its PE low, that would represent a price of 14.14, which is a decrease of -0.00%.
Below was the last reported quarterly earnings per share:
Base on our calculations, the intrinsic value per share is 15.49, which means it might be undervalued and has a margin of safety of 8.73%
Indicators Also to Watch:
Based on the latest filings, there is 14.70% of insider ownership and 140.30% of institutional ownership.
I calculated the beta to be 0.66
Based on last reported financials, the company’s return on equity is 27.96%, return on assets is 16.76%, profit margin is -3.82%, price-to-sales is 1.65 and price-to-book is 2.75.
Company Score Card:
Results are out of six:
4 : Growth Expectations Result
6 : Financial Safety Result
4 : Past Performance Result
4 : Valuation Result
0 : Dividend Safety Result
4 : Overall Result